Evonik Vland Biotech JV commences operations
Grand opening of the joint venture between Evonik China and Shandong Vland Biotech in Qingdao, China
Grand opening of the joint venture between Evonik China and Shandong Vland Biotech in Qingdao, China
Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals
This partnership marks a significant step for the Company towards establishing renewable energy power generation using hybrid open excess through solar and wind sources
Acquisition broadens oncology pipeline with a portfolio of novel T-cell engagers including HPN328 (MK-6070), an investigational delta-like ligand 3 (DLL3) targeting T-cell engager
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
AbCellera will receive an upfront payment and is eligible to receive additional milestone payments
With this, the total number of Patents granted to company for its innovative processes and technology stands at 9
ICMR’s budgetary allowance has increased by 4-fold in the past 10 years, showcasing our commitment towards Health Research
Patients visiting OPD sections of hospitals use their Ayushman Bharat Health Account (ABHA) to get instant tokens to save time spent in registration queues
Subscribe To Our Newsletter & Stay Updated